Contact this trialFirst, we need to learn more about you.
MK-8189 for Schizophrenia
Recruiting0 awardsPhase 2
Shreveport, Louisiana
This trial is testing if MK-8189 is an effective and safe treatment for schizophrenia according to DSM-5 criteria. The primary hypotheses are that MK-8189 24mg and 16mg are superior to placebo in reducing PANSS total score.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.